No Data
No Data
Possible Bearish Signals With Incyte Insiders Disposing Stock
Express News | Incyte Announces Health Canada Approval of Opzelura (Ruxolitinib) Cream for Treatment of Atopic Dermatitis (Ad) and Nonsegmental Vitiligo
Incyte Announces Health Canada Approval of OPZELURA (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo
What to Expect From Incyte's Next Quarterly Earnings Report
Express News | Knight Therapeutics Announces Approval of Minjuvi® (Tafasitamab) in Mexico
Knight Therapeutics Announces Approval of Minjuvi (Tafasitamab) in Mexico